0001209191-13-045743.txt : 20130926 0001209191-13-045743.hdr.sgml : 20130926 20130926140928 ACCESSION NUMBER: 0001209191-13-045743 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130925 FILED AS OF DATE: 20130926 DATE AS OF CHANGE: 20130926 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SACHS BRUCE I CENTRAL INDEX KEY: 0001197036 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 131116483 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-09-25 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197036 SACHS BRUCE I C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2013-09-25 4 S 0 5800 74.86 D 73910 D Common Stock 2013-09-25 4 S 0 2500 75.23 D 71410 D Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $74.86 (range $74.48 to $74.99). Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $75.23 (range $75.00 to $75.69). Kenneth L. Horton, Attorney-In-Fact 2013-09-26